Insulin-like growth factor axis and oncogenic human papillomavirus natural history

Tiffany G. Harris, Robert D. Burk, Herbert Yu, Howard Minkoff, L. Stewart Massad, D. Heather Watts, Ye Zhong, Stephen Gange, Robert C. Kaplan, Kathryn Anastos, Alexandra M. Levine, Michael Moxley, Xiaonan Xue, Melissa Fazzari, Joel M. Palefsky, Howard D. Strickler

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

High serum levels of insulin-like growth factor-I (IGF-I) are reported to be a risk factor for several common cancers, and recent cross-sectional data suggest a possible additional association of IGF-I with cervical neoplasia. To prospectively assess whether circulating IGF-I levels influence the natural history of oncogenic human papillomavirus (HPV), the viral cause of cervical cancer, we conducted a pilot investigation of 137 women who underwent semiannual type specific HPV DNA PCR testing and cervical cytology. Total IGF-I and IGF binding protein-3 (IGFBP-3), the most abundant IGFBP in circulation, were measured using baseline serum specimens. Having a high IGF-I/ IGFBP-3 ratio was associated with increased persistence of oncogenic HPV infection [that is, a lower rate of clearance; adjusted hazard ratio (AHR), 0.14; 95% confidence interval (95% CI), 0.04-0.57], whereas IGFBP-3 was inversely associated with both the incident detection of oncogenic HPV (AHR, 0.35; 95% CI, 0.13-0.93) and the incidence of oncogenic HPV-positive cervical neoplasia (that is, squamous intraepithelial lesions at risk of progression; AHR, 0.07; 95% CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV.

Original languageEnglish (US)
Pages (from-to)245-248
Number of pages4
JournalCancer Epidemiology Biomarkers and Prevention
Volume17
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

Somatomedins
Natural History
Insulin-Like Growth Factor I
Insulin-Like Growth Factor Binding Protein 3
Insulin-Like Growth Factor Binding Proteins
Confidence Intervals
Neoplasms
Papillomavirus Infections
Serum
Uterine Cervical Neoplasms
Cell Biology
Polymerase Chain Reaction
DNA
Incidence

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Cite this

Insulin-like growth factor axis and oncogenic human papillomavirus natural history. / Harris, Tiffany G.; Burk, Robert D.; Yu, Herbert; Minkoff, Howard; Massad, L. Stewart; Watts, D. Heather; Zhong, Ye; Gange, Stephen; Kaplan, Robert C.; Anastos, Kathryn; Levine, Alexandra M.; Moxley, Michael; Xue, Xiaonan; Fazzari, Melissa; Palefsky, Joel M.; Strickler, Howard D.

In: Cancer Epidemiology Biomarkers and Prevention, Vol. 17, No. 1, 01.01.2008, p. 245-248.

Research output: Contribution to journalArticle

Harris, Tiffany G. ; Burk, Robert D. ; Yu, Herbert ; Minkoff, Howard ; Massad, L. Stewart ; Watts, D. Heather ; Zhong, Ye ; Gange, Stephen ; Kaplan, Robert C. ; Anastos, Kathryn ; Levine, Alexandra M. ; Moxley, Michael ; Xue, Xiaonan ; Fazzari, Melissa ; Palefsky, Joel M. ; Strickler, Howard D. / Insulin-like growth factor axis and oncogenic human papillomavirus natural history. In: Cancer Epidemiology Biomarkers and Prevention. 2008 ; Vol. 17, No. 1. pp. 245-248.
@article{edc91cb85e804140b5f848af14fffa9a,
title = "Insulin-like growth factor axis and oncogenic human papillomavirus natural history",
abstract = "High serum levels of insulin-like growth factor-I (IGF-I) are reported to be a risk factor for several common cancers, and recent cross-sectional data suggest a possible additional association of IGF-I with cervical neoplasia. To prospectively assess whether circulating IGF-I levels influence the natural history of oncogenic human papillomavirus (HPV), the viral cause of cervical cancer, we conducted a pilot investigation of 137 women who underwent semiannual type specific HPV DNA PCR testing and cervical cytology. Total IGF-I and IGF binding protein-3 (IGFBP-3), the most abundant IGFBP in circulation, were measured using baseline serum specimens. Having a high IGF-I/ IGFBP-3 ratio was associated with increased persistence of oncogenic HPV infection [that is, a lower rate of clearance; adjusted hazard ratio (AHR), 0.14; 95{\%} confidence interval (95{\%} CI), 0.04-0.57], whereas IGFBP-3 was inversely associated with both the incident detection of oncogenic HPV (AHR, 0.35; 95{\%} CI, 0.13-0.93) and the incidence of oncogenic HPV-positive cervical neoplasia (that is, squamous intraepithelial lesions at risk of progression; AHR, 0.07; 95{\%} CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV.",
author = "Harris, {Tiffany G.} and Burk, {Robert D.} and Herbert Yu and Howard Minkoff and Massad, {L. Stewart} and Watts, {D. Heather} and Ye Zhong and Stephen Gange and Kaplan, {Robert C.} and Kathryn Anastos and Levine, {Alexandra M.} and Michael Moxley and Xiaonan Xue and Melissa Fazzari and Palefsky, {Joel M.} and Strickler, {Howard D.}",
year = "2008",
month = "1",
day = "1",
doi = "10.1158/1055-9965.EPI-07-0686",
language = "English (US)",
volume = "17",
pages = "245--248",
journal = "Cancer Epidemiology Biomarkers and Prevention",
issn = "1055-9965",
publisher = "American Association for Cancer Research Inc.",
number = "1",

}

TY - JOUR

T1 - Insulin-like growth factor axis and oncogenic human papillomavirus natural history

AU - Harris, Tiffany G.

AU - Burk, Robert D.

AU - Yu, Herbert

AU - Minkoff, Howard

AU - Massad, L. Stewart

AU - Watts, D. Heather

AU - Zhong, Ye

AU - Gange, Stephen

AU - Kaplan, Robert C.

AU - Anastos, Kathryn

AU - Levine, Alexandra M.

AU - Moxley, Michael

AU - Xue, Xiaonan

AU - Fazzari, Melissa

AU - Palefsky, Joel M.

AU - Strickler, Howard D.

PY - 2008/1/1

Y1 - 2008/1/1

N2 - High serum levels of insulin-like growth factor-I (IGF-I) are reported to be a risk factor for several common cancers, and recent cross-sectional data suggest a possible additional association of IGF-I with cervical neoplasia. To prospectively assess whether circulating IGF-I levels influence the natural history of oncogenic human papillomavirus (HPV), the viral cause of cervical cancer, we conducted a pilot investigation of 137 women who underwent semiannual type specific HPV DNA PCR testing and cervical cytology. Total IGF-I and IGF binding protein-3 (IGFBP-3), the most abundant IGFBP in circulation, were measured using baseline serum specimens. Having a high IGF-I/ IGFBP-3 ratio was associated with increased persistence of oncogenic HPV infection [that is, a lower rate of clearance; adjusted hazard ratio (AHR), 0.14; 95% confidence interval (95% CI), 0.04-0.57], whereas IGFBP-3 was inversely associated with both the incident detection of oncogenic HPV (AHR, 0.35; 95% CI, 0.13-0.93) and the incidence of oncogenic HPV-positive cervical neoplasia (that is, squamous intraepithelial lesions at risk of progression; AHR, 0.07; 95% CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV.

AB - High serum levels of insulin-like growth factor-I (IGF-I) are reported to be a risk factor for several common cancers, and recent cross-sectional data suggest a possible additional association of IGF-I with cervical neoplasia. To prospectively assess whether circulating IGF-I levels influence the natural history of oncogenic human papillomavirus (HPV), the viral cause of cervical cancer, we conducted a pilot investigation of 137 women who underwent semiannual type specific HPV DNA PCR testing and cervical cytology. Total IGF-I and IGF binding protein-3 (IGFBP-3), the most abundant IGFBP in circulation, were measured using baseline serum specimens. Having a high IGF-I/ IGFBP-3 ratio was associated with increased persistence of oncogenic HPV infection [that is, a lower rate of clearance; adjusted hazard ratio (AHR), 0.14; 95% confidence interval (95% CI), 0.04-0.57], whereas IGFBP-3 was inversely associated with both the incident detection of oncogenic HPV (AHR, 0.35; 95% CI, 0.13-0.93) and the incidence of oncogenic HPV-positive cervical neoplasia (that is, squamous intraepithelial lesions at risk of progression; AHR, 0.07; 95% CI, 0.01-0.66). These prospective data provide initial evidence that the IGF axis may influence the natural history of oncogenic HPV.

UR - http://www.scopus.com/inward/record.url?scp=38849168064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38849168064&partnerID=8YFLogxK

U2 - 10.1158/1055-9965.EPI-07-0686

DO - 10.1158/1055-9965.EPI-07-0686

M3 - Article

C2 - 18199731

AN - SCOPUS:38849168064

VL - 17

SP - 245

EP - 248

JO - Cancer Epidemiology Biomarkers and Prevention

JF - Cancer Epidemiology Biomarkers and Prevention

SN - 1055-9965

IS - 1

ER -